Expanding Our Global Consulting Expertise to Solve Mission-Critical Issues
Elevating our consulting capabilities to accelerate clinical research and bring therapies to market sooner.
Does Warp Speed Vaccine Development and Testing Compromise Safety?
Fiction often shows warp speed travels not going as planned, but what does warp speed mean for vaccine development in clinical research?
Top 10 Educational Resources of 2020
We strive to create meaningful and relevant content for the clinical research community. Check out our top resources of 2020.
New FDA Certificate of Confidentiality Guidance: What Does it Mean for You?
Certificates of Confidentiality protect participant privacy by preventing disclosed sensitive information during research.
What is the ROI of eLearning?
Learn how to launch an eLearning program for Clinical Research. eLearning is a tool for software implementations, staff development, and procedure training.
Community-Based Participatory Research (CBPR): A Framework for Community Engagement
Community-based participatory research (CBPR) is utilized to reduce racial and ethnic health disparities in under-represented populations.
Q&A – How Medicare’s New Imaging Program Affects Clinical Trials in Oncology
Jake Meyer answers the most popular questions from his latest webinar: How Medicare’s New Imaging Program Affects Clinical Trials in Oncology.
Standardization and the Importance of Medical Coding Dictionaries in Clinical Trials
Learn more about the importance of medical coding dictionaries, their common uses, and best practices.
The Many Faces of “Coercion” and “Undue Influence”
Coercion and undue influence in research can be complicated. Understand what these terms mean and how to appropriately protect against them.
Coming Together to Benefit the Greater Research Community
Advarra acquires Longboat to help advance clinical research and accelerate drug development.
Q&A – Racial Diversity in Clinical Trials: Building Trust in Participant Engagement
Our experts answered some of the most popular questions from "Racial Diversity in Clinical Trials: Building Trust in Participant Engagement."
Surprise! “Checking the Box” Is Still an Option on the Federalwide Assurance (FWA)
Checking the box is still an option on the FWA. At this time, institutions must carefully consider whether it makes sense to check the box.